ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 114 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $40,376,000 | +39.9% | 1,143,790 | 0.0% | 0.51% | +64.8% |
| Q4 2020 | $28,869,000 | -33.1% | 1,143,790 | 0.0% | 0.31% | -50.8% |
| Q3 2020 | $43,132,000 | -34.8% | 1,143,790 | -25.9% | 0.63% | -41.2% |
| Q2 2020 | $66,105,000 | +120.3% | 1,543,790 | 0.0% | 1.07% | +37.0% |
| Q1 2020 | $30,011,000 | -25.2% | 1,543,790 | 0.0% | 0.78% | -1.9% |
| Q4 2019 | $40,107,000 | -4.7% | 1,543,790 | 0.0% | 0.80% | -29.7% |
| Q3 2019 | $42,075,000 | +1.5% | 1,543,790 | 0.0% | 1.13% | +19.2% |
| Q2 2019 | $41,450,000 | -7.1% | 1,543,790 | 0.0% | 0.95% | -24.5% |
| Q1 2019 | $44,630,000 | +7.4% | 1,543,790 | 0.0% | 1.26% | -20.4% |
| Q4 2018 | $41,574,000 | – | 1,543,790 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |